A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids

Details for Australian Patent Application No. 2006254554 (hide)

Owner Egalet Ltd

Inventors Bar-Shalom, Daniel; Slot, Lillian

Agent FB Rice

Pub. Number AU-B-2006254554

PCT Pub. Number WO2006/128471

Priority PA 2005 00813 03.06.05 DK

Filing date 2 June 2006

Wipo publication date 7 December 2006

Acceptance publication date 24 November 2011

International Classifications

A61K 9/32 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 38/23 (2006.01) Medicinal preparations containing peptides - Calcitonins

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/128471 Priority application(s): WO2006/128471

16 December 2010 Assignment before Grant

  Egalet A/S The application has been assigned to Egalet Ltd

24 November 2011 Application Accepted

  Published as AU-B-2006254554

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254570-Concentrator photovoltaic device, PV concentrator module formed therefrom and production process therefor

2006254548-Phosphatidylserine enriched milk fractions for the formulation of functional foods